LEXINGTON, Mass., May 30, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at Jefferies 2012 Global Healthcare Conference at 3:30 p.m. ET on June 6, 2012, in New York City.
